series-c-plus
Stage
2010
Founded
3
Investors
About
Seres Therapeutics develops microbiome therapeutics aimed at treating diseases by modulating the human microbiome.
Explore Seres Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.